NYSEARCA:PPH - Market Vectors Pharmaceutical ETF Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$60.32 -0.22 (-0.36 %)
(As of 06/21/2018 12:02 PM ET)
Previous Close$60.34
Today's Range$60.26 - $60.34
52-Week Range$53.83 - $64.65
Volume1,800 shs
Average Volume102,270 shs
Market Capitalization$354.64 million
P/E RatioN/A
Dividend Yield1.78%
Beta0.85

Receive PPH News and Ratings via Email

Sign-up to receive the latest news and ratings for PPH and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
SymbolNYSEARCA:PPH
CUSIPN/A
PhoneN/A

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

EmployeesN/A
Outstanding Shares4,738,000

Market Vectors Pharmaceutical ETF (NYSEARCA:PPH) Frequently Asked Questions

What is Market Vectors Pharmaceutical ETF's stock symbol?

Market Vectors Pharmaceutical ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PPH."

How often does Market Vectors Pharmaceutical ETF pay dividends? What is the dividend yield for Market Vectors Pharmaceutical ETF?

Market Vectors Pharmaceutical ETF announced a quarterly dividend on Tuesday, January 30th. Shareholders of record on Tuesday, April 3rd will be paid a dividend of $0.394 per share on Friday, April 6th. This represents a $1.58 dividend on an annualized basis and a yield of 2.61%. The ex-dividend date of this dividend is Monday, April 2nd. View Market Vectors Pharmaceutical ETF's Dividend History.

Are investors shorting Market Vectors Pharmaceutical ETF?

Market Vectors Pharmaceutical ETF saw a decline in short interest in the month of May. As of May 31st, there was short interest totalling 988,493 shares, a decline of 39.7% from the May 15th total of 1,638,589 shares. Based on an average trading volume of 74,019 shares, the short-interest ratio is currently 13.4 days. View Market Vectors Pharmaceutical ETF's Current Options Chain.

Has Market Vectors Pharmaceutical ETF been receiving favorable news coverage?

Media coverage about PPH stock has trended somewhat positive on Thursday, Accern Sentiment reports. Accern ranks the sentiment of news coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Market Vectors Pharmaceutical ETF earned a media sentiment score of 0.10 on Accern's scale. They also assigned headlines about the company an impact score of 47.05 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company's share price in the immediate future.

Who are Market Vectors Pharmaceutical ETF's major shareholders?

Market Vectors Pharmaceutical ETF's stock is owned by a number of of institutional and retail investors. Top institutional investors include SG Americas Securities LLC (1.18%), Jane Street Group LLC (0.54%), Citadel Advisors LLC (0.45%), UBS Group AG (0.39%), Mutual Advisors LLC (0.34%) and LPL Financial LLC (0.30%). View Institutional Ownership Trends for Market Vectors Pharmaceutical ETF.

Which institutional investors are selling Market Vectors Pharmaceutical ETF stock?

PPH stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Jane Street Group LLC, Wayne Hummer Investments L.L.C. and LPL Financial LLC. View Insider Buying and Selling for Market Vectors Pharmaceutical ETF.

Which institutional investors are buying Market Vectors Pharmaceutical ETF stock?

PPH stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, Mutual Advisors LLC, Citadel Advisors LLC and Royal Bank of Canada. View Insider Buying and Selling for Market Vectors Pharmaceutical ETF.

How do I buy shares of Market Vectors Pharmaceutical ETF?

Shares of PPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Market Vectors Pharmaceutical ETF's stock price today?

One share of PPH stock can currently be purchased for approximately $60.32.

How big of a company is Market Vectors Pharmaceutical ETF?

Market Vectors Pharmaceutical ETF has a market capitalization of $354.64 million.


MarketBeat Community Rating for Market Vectors Pharmaceutical ETF (PPH)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  15 (Vote Underperform)
Total Votes:  29
MarketBeat's community ratings are surveys of what our community members think about Market Vectors Pharmaceutical ETF and other stocks. Vote "Outperform" if you believe PPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 6/21/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.